Prurigo Nodularis market to exhibit growth at a CAGR of 23.2% (2020-2034), driven by strong uptake of DUPIXENT, recent approval of NEMLUVIO, promising JAK and OX40 inhibitors in the Pipeline, along ...

Patients with rheumatoid arthritis increased their leg muscle volume when treated with an anti-rheumatic drug, offering new ...

Called sonelokimab, the product inhibits both the A and F isoforms of interleukin-17 (IL-17). In this mid-stage trial, well ...

A new treatment for a debilitating inflammatory condition which affects joints and skin has shown promising early results in ...

A team of chemists at Cambridge University has created an artificial cartilage material that can precisely release drugs over ...

Arthritis affects more than 10 million people in the UK – roughly one-sixth of the population. It can be a painful, even debilitating, condition that affects people’s ability to perform and/or enjoy a ...

South Korea's Hyundai ADM Bio said its new cancer drug under development, Penetrium, may prove effective treating diseases ...

In a study from Korea, adults with type 2 diabetes had a lower risk for autoimmune rheumatic diseases after starting an SGLT2 ...

Korean researchers found that low-dose radiation therapy eased knee pain and improved movement in people with mild to ...

Please provide your email address to receive an email when new articles are posted on . The FDA expanded the indication for Tremfya (guselkumab) to children with plaque psoriasis or active psoriatic ...

A sweeping analysis of nearly 10,000 patients reveals that knee braces, hydrotherapy, and exercise stand out as the most effective non-drug therapies for knee osteoarthritis. Unlike common pain ...

Russian pharmaceutical company R-Pharm is working to retool rheumatoid arthritis drug, olokizumab, to treat COVID-19 patients with moderate to severe infections, its Chief Medical Officer Mikhail ...